Kaplan–Meier survival analysis indicated that patients with low SORBS2 had a poorer overall survival than those belonging to high SORBS2 levels in ccRCC (Fig. 1E). The gene discussed is SORBS2; the disease is nonpapillary renal cell carcinoma.